1Parkin DM,Bray F,Ferlay J,et al.Global Cancer Statistics[J].CA Cancer J Clin,2005,55:74-108.
2Luini A,Gatti G,Galimberti V,et al.Conservative treatment of breast cancer:its evolution[J].Breast Cancer Research and Treatment,2005,94:195-198.
3Foote RL,Johnson RE,Donohue JH,et al.Trends in surgical treatment of breast cancer at Mayo Clinic1980~2004[J].The Breast,2008,17:555-562.
4Voogd AC,Nielsen M,Peterse JL,et al.Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and IIbreast cancer:pooled results of two large european randomized trials[J].Jour-nal of Clinical Oncology,2001,19(6):1688-1697.
5Jatoi I,Proschan MA.Randomized trials of breast-conserving therapy versus mas-tectomy for primary breast cancer:A pooled analysis of updated results[J].Am J Clin Oncol,2005,28(3):289-294.
6Early Breast Cancer Trialists’Collaborative Group(EBCTCG).Effects of radio-therapy and of differences in the extent of surgery for early breast cancer on local recurrence and15-year survival:An overviewof the randomised trials[J].Lan-cet,2005,366(9503):2087-2106.
7Higgins JPT,Altman DG(editors):Chapter8:Assessing risk of bias in includ-ed studies.In:Higgins JPT,Green S(editors).Cochrane handbook for systematic reviews of interventions version5.0.0(updated February2008).The Cochrane Collaboration,2008.Available from URL:http://www.cochrane-handbook.org.
8Wu TX,Liu GJ.The concepts,design,practice and report of allocation conceal-ment and blinding[J].Chinese Journal of Evidence-Based Medicine,2007,7(3):219-222.
9Fentiman IS,van-Zijl J,Karydas I,etal.Treatmentof operable breastcancer in the elderly:a randomised clinical trial EORTC10850comparing modified radical mastectomy with tumorectomy plus tamoxifen[J].European Journal of Cancer,2003,39:300-308.
10Gori J,Castano R,Engel H,et al.Conservative treatment vs mastectomy without radiotherapy in aged women with breast cancer-Aprospective and randomized tri-al[Conservative treatment vs.mastectomy without radiotherapy in aged women with breast cancer-A prospective and randomized trial][J].Zentralbl Gynakol,2000,122:311-317.
11van-Zyl JA,Muller AGS.Tumour excision plus continuous tamoxifen compared with modified radical mastectomy in patients over70years of age with operable breast cancer[J].Journal of Surgical Oncology,1995,59:151-154.
12Mustacchi G,Cazzaniga ME,Pronzato P,et al.Breast cancer in elderly women:a different reality-Results from the NORAstudy[J].Ann Oncol,2007,18:991-996.
13Ma CD,Zhou Q,Nie XQ,et al.Breast cancer in Chinese elderly women:patho-logical and clinical characteristics and factors influencingtreatmentpatterns[J].Crit Rev Oncol/Hematol,(2009)doi:10.1016/j.critrevonc.200811.005.
14Gentilini O,Botteri E,Rotmensz N,et al.Conservative surgery in patients with multifocal/multicentric breast cancer[J].Breast Cancer Res Treat,2009,113:577-583.
15Loibl S,von-Minckwitz G,Raab G,et al.Surgical procedures after neoadjuvant chemotherapy in operable breast cancer:Results of the GEPARDUO Trial[J].Annals of Surgical Oncology,2006,13(11):1434-1442.
16Smith IE.Neoadjuvant endocrine therapy:clinical and biological issues[J].Breast Cancer Research,2007,9(Suppl1):S19.
17Chen XS,Nie XQ,Chen CM,etal.Weekly paclitaxel plus carboplatin is an effec-tive nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer[J].Ann Oncol,2010,21(5):961-967.
18Han S,Kim J,Lee J,et al.Comparison of6cycles versus4cycles of neoadjuvant epirubicin plus docetaxel chemotherapy in stages II and III breast cancer[J].Eur J Surg Oncol,2009,35(6):583-587.
19Liu SV,Melstrom L,Yao K,et al.Neoadjuvant therapy for breast cancer[J].J Surg Oncol,2010,101(4):283-291. |